Gilead Sciences, Inc. (GILD)
131.27
+5.30
(+4.21%)
USD |
NASDAQ |
Jul 02, 16:00
130.95
-0.32
(-0.24%)
After-Hours: 20:00
Gilead Sciences Price : 131.27 for July 2, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 02, 2026 | 126.72 | 131.58 | 126.46 | 131.27 | 8.089M |
| Jul 01, 2026 | 127.28 | 127.62 | 125.12 | 125.97 | 6.655M |
| Jun 30, 2026 | 125.88 | 127.27 | 124.19 | 126.34 | 7.410M |
| Jun 29, 2026 | 128.86 | 128.86 | 125.49 | 126.33 | 6.898M |
| Jun 26, 2026 | 125.25 | 128.70 | 125.00 | 127.88 | 19.91M |
| Jun 25, 2026 | 125.27 | 126.95 | 123.67 | 123.84 | 7.251M |
| Jun 24, 2026 | 125.56 | 127.27 | 124.78 | 125.16 | 7.410M |
| Jun 23, 2026 | 126.63 | 126.63 | 124.44 | 125.05 | 8.463M |
| Jun 22, 2026 | 124.30 | 125.17 | 123.00 | 124.87 | 8.126M |
| Jun 18, 2026 | 125.84 | 126.39 | 122.43 | 123.76 | 14.35M |
| Jun 17, 2026 | 126.69 | 128.20 | 124.11 | 125.45 | 7.727M |
| Jun 16, 2026 | 125.22 | 128.18 | 124.14 | 127.23 | 9.382M |
| Jun 15, 2026 | 125.29 | 125.40 | 122.70 | 124.30 | 6.653M |
| Jun 12, 2026 | 126.13 | 126.50 | 124.29 | 125.59 | 5.216M |
| Jun 11, 2026 | 121.79 | 127.37 | 121.79 | 125.87 | 8.666M |
| Jun 10, 2026 | 125.18 | 125.64 | 121.39 | 121.48 | 10.15M |
| Jun 09, 2026 | 128.80 | 129.00 | 123.20 | 125.50 | 8.683M |
| Jun 08, 2026 | 130.07 | 130.80 | 127.13 | 128.10 | 9.796M |
| Jun 05, 2026 | 130.09 | 131.66 | 128.92 | 129.16 | 15.37M |
| Jun 04, 2026 | 130.57 | 131.04 | 128.01 | 129.18 | 13.73M |
| Jun 03, 2026 | 127.59 | 129.86 | 127.50 | 128.99 | 6.237M |
| Jun 02, 2026 | 128.99 | 130.60 | 127.07 | 127.57 | 8.083M |
| Jun 01, 2026 | 133.99 | 133.99 | 130.53 | 131.10 | 6.259M |
| May 29, 2026 | 135.12 | 137.20 | 133.54 | 134.43 | 17.51M |
| May 28, 2026 | 133.89 | 136.51 | 132.79 | 136.22 | 5.612M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 261.07 |
| Biogen, Inc. | 216.12 |
| Amgen, Inc. | 374.15 |
| Johnson & Johnson | 263.04 |
| Eli Lilly & Co. | 1213.91 |
Price Related Metrics
| PE Ratio | 17.86 |
| PS Ratio | 5.526 |
| PEG Ratio | 0.3275 |
| Price to Book Value | 6.933 |
| Price to Free Cash Flow | 16.09 |
| Earnings Yield | 5.60% |
| Market Cap | 163.04B |
| PEGY Ratio | 0.3134 |
| Operating PE Ratio | 13.68 |
| Normalized PE Ratio | 17.01 |